ReviewNeurosurgical review2026
Extracellular matrix remodeling and internal elastic lamina alterations in cerebral arteriovenous malformations: Insights into vascular wall biology.
Review in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebral arteriovenous malformations (cAVMs) are high-flow vascular lesions associated with a relevant risk of intracranial hemorrhage. Beyond angioarchitectural determinants, emerging evidence suggests that alterations of the internal elastic lamina (IEL) and elastic fiber network may contribute to vascular remodeling and structural instability. We conducted a structured qualitative literature review with narrative synthesis, without quantitative meta-analysis because of substantial methodological and biological heterogeneity across studies. We included histological, molecular, and genetic investigations addressing elastin biology, IEL structure, extracellular matrix remodeling, and related signaling pathways in cAVMs within the broader context of vascular wall biology. Twenty studies met the predefined inclusion criteria. Direct histopathological evidence of IEL fragmentation was identified in only two primary studies, whereas additional histological investigations reported structural abnormalities including IEL disorganization, interruption, or irregular thickening. Molecular studies consistently described dysregulation of KRAS-MAPK, Notch, and BMP9/ALK1 signaling pathways involved in vascular endothelial homeostasis and extracellular matrix remodeling, although most did not directly evaluate IEL or elastic fiber architecture. Collectively, these findings support biologically plausible mechanisms of vascular remodeling rather than a unified mechanistic cascade. Similarities with inherited disorders affecting elastogenesis represent mechanistic analogies rather than evidence of shared disease pathogenesis. Alterations of the IEL and elastic fiber network may represent a relevant component of the structural phenotype of cAVMs, potentially acting as downstream or parallel manifestations within a multifactorial biological framework. Integrating histopathological and molecular evidence may improve the biological characterization of these lesions and support future hypothesis generation regarding vascular stability. However, the currently available evidence does not allow causal inference regarding the role of IEL alterations or elastic fiber disruption in cAVM pathogenesis or rupture susceptibility.
Indexed as
Identifiers
42749821What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.